| Prev Close | 57.71 |
| Open | 57.58 |
| Day Low/High | 57.18 / 58.86 |
| 52 Wk Low/High | 43.51 / 72.41 |
| Volume | 241.29K |
| Avg Volume | 396.50K |
Latest News
NuVasive LessRay® Platform Wins Gold At 2019 Medical Design Excellence Awards
Platform significantly reduces radiation exposure by up to 75 percent, helping make the operating room safer for staff and patients
NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System
SpineTRACK represents the only industry-sponsored spine registry that qualified providers to receive positive payment adjustments up to seven percent on all Medicare reimbursements in 2020
NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting
SAN DIEGO, May 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company continues its...
NuVasive To Present At The Bank Of America Merrill Lynch Healthcare Conference 2019
SAN DIEGO, May 6, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will...
NuVasive Announces First Quarter 2019 Financial Results
SAN DIEGO, May 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the...
Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK
SAN DIEGO, April 22, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the...
NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results
SAN DIEGO, April 15, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will...
Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360™ System At AANS 2019
Integrated Procedural System Advances Approach to Minimally Invasive Surgery
NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards
Platform designed to significantly reduce radiation exposure helps make the OR safer for staff and patients
NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases
NuVasive Expands Applications of Porous PEEK Surface Technology to Lateral Surgery with First-of-its-Kind Cohere® XLIF Implant
NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At Spine Summit 2019
Company sponsors Spine Summit 2019 - 35th Annual Meeting of the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves
NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference
SAN DIEGO, March 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management...
NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference
SAN DIEGO, Feb. 21, 2019 /PRNewswire/ -- NuVasive, Inc.
NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results
Company provides 2019 financial performance guidance
NuVasive's Proprietary Magnetic Implant System To Be Used In First-Of-Its-Kind, All-Internal Bone Transport System
Company receives FDA 510(k) clearance and CE mark approval for use of minimally invasive Precice® Bone Transport System to treat segmental bone defects up to 10 centimeters in the tibia and femur
NuVasive Stock Surges on Report of Smith & Nephew Interest
Shares surge after a report says London-based Smith & Nephew is considering buying the company.
Stocks Mixed Ahead of U.S.-China Trade Talks; Healthcare Sector Weighs on Dow
The Dow Jones Industrial Average falls as investors eye progress in this week's renewed U.S.-China trade talks.
Trade Talks, Shutdown, NuVasive, Activision, Amazon - 5 Things You Must Know
U.S. stock futures are higher as U.S.-China trade talks resume; Republican and Democratic lawmakers are working to broker an agreement that will prevent another government shutdown on Friday; Smith & Nephew reportedly has held talks to buy NuVasive; Activision could announce job cuts when it reports earnings Tuesday.
NuVasive Announces Conference Call And Webcast Of Fourth Quarter And Full Year 2018 Results
SAN DIEGO, Jan. 29, 2019 /PRNewswire/ -- NuVasive, Inc.
NuVasive Announces Preliminary Unaudited Fourth Quarter And Full Year 2018 Revenue Results
SAN DIEGO, Jan. 7, 2019 /PRNewswire/ -- NuVasive, Inc.
NuVasive CEO J. Christopher Barry Announces New Organizational Structure And Leadership Team
SAN DIEGO, Jan. 3, 2019 /PRNewswire/ -- NuVasive, Inc.
NuVasive To Participate In 37th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 27, 2018 /PRNewswire/ -- NuVasive, Inc.
Biglari Holdings Doesn’t Look Appetizing, Plus 4 Other Good Short Candidates
BH, ENLK, R, DVN and NUVA were all recently downgraded by TheStreet’s Quant Ratings service.
Ratings Changes Today
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BXMT, CHK, CHMI, CWEN, CWEN.A, EBMT, EFC, HASI, HIIQ, HMST, HTBI, HY, HZNP, JTPY, KNDI, LARK, LMRK, MBI, MFNC, MFSF, PBFX, RC, TEUM, UBNK, URG Downgrades: APTV, CFBK, CNFR, CPLP, CVEO, HF, HNGR, HPJ, IAG, INS, LGL, MAA, MCRN, MDRX, MHH, MTLS, NFBK, NUVA, OFED, OMI, VTSI, WNC, WSTL Initiations: I, ONS Read on to get TheStreet Quant Ratings' detailed report:
Ratings Changes Today
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHEF, CLH, DYSL, FLR, FORM, GPOR, HI, IBM, KBR, KW, NUVA, TGE, WSTL, X Downgrades: EMKR, PSMT, SEB Initiations: APPN, APRN, GDI Read on to get TheStreet Quant Ratings' detailed report:
First Week of May 18th Options Trading For Nuvasive Inc (NUVA)
Investors in Nuvasive Inc saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NUVA options chain for the new May 18th contracts and identified one put and one call contract of particular interest.
NUVA: Insiders vs. Shorts
The most recent short interest data was recently released for the 11/30/2017 settlement date, and Nuvasive Inc is one of the most shorted stocks of the Russell 3000, based on 10.32 "days to cover" versus the median component at 5.11. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
Which Way Are These Stocks Going?
Finding bullish and bearish reversals in the market.
